KAS
ANIK icon

Kemnay Advisory Services’s Anika Therapeutics ANIK Stock Holding History

Kemnay Advisory Services’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$99.6K Buy
+6,869
New +$79.7K 0.02% 116

Other funds holding ANIK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CM
Capital Management Glen Allen, Virginia $585M AUM 5.18% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Kemnay Advisory Services's ANIK Position: Q1 2026 in Review

Kemnay Advisory Services opened a new position in Anika Therapeutics (ANIK) in Q1 2026: 6,869 shares worth $99.6K. The stake represents 0.02% of the portfolio and ranks #116 among its holdings.

130 funds tracked by Wall St. Rank hold ANIK as of Q1 2026.

  • Kemnay Advisory Services held 6,869 shares of Anika Therapeutics worth $99.6K as of Q1 2026.
  • Anika Therapeutics was a new Kemnay Advisory Services position in Q1 2026.
  • Anika Therapeutics made up 0.02% of Kemnay Advisory Services's portfolio in Q1 2026, its #116 holding.
  • 130 funds tracked by Wall St. Rank held Anika Therapeutics as of Q1 2026.

Based on Kemnay Advisory Services's 13F filing for Q1 2026, filed 15 May 2026.